• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Meridian Bioscience, Inc. (VIVO)

    -NasdaqGS
    19.11 Down 0.74(3.73%) 4:00PM EDT
    |After Hours : 19.32 Up 0.21 (1.10%) 7:54PM EDT
    ProfileGet Profile for:
    Meridian Bioscience, Inc.
    3471 River Hills Drive
    Cincinnati, OH 45244
    United States - Map
    Phone: 513-271-3700
    Fax: 513-271-3762
    Website: http://www.meridianbioscience.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Diagnostic Substances
    Full Time Employees:580

    Business Summary 

    Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays that can be used in point-of-care settings under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; and enzyme-linked immunoassays under the Premier brand. This segment’s products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of C. difficile, a causative agent for antibiotic-associated diarrhea from a hospital-acquired infection; foodborne products, such as tests for Enterohemorrhagic E. coli and Campylobacter jejuni; Helicobacter pylori to detect peptic ulcers; respiratory products; and tests to detect Group B Streptococcu, Chlamydia trachomatis, Neisseria gonorrhea, and Herpes Simplex Virus Type 1 and Type 2. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, and outpatient clinics. The Life Science segment develops, manufactures, sells, and distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic manufacturing companies. It also provides contract development and manufacturing services under clinical cGMP conditions for biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Meridian Bioscience, Inc.

    Corporate Governance 
    Meridian Bioscience, Inc.’s ISS Governance QuickScore as of Apr 1, 2016 is 4. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 6; Compensation: 4.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. John A. Kraeutler , 68
    Chairman, Chief Exec. Officer and Pres
    719.00K93.00K
    Ms. Melissa A. Lueke , 53
    Chief Financial Officer, Exec. VP and Sec.
    331.00K93.00K
    Mr. Richard L. Eberly , 55
    Exec. VP and Pres of Meridian Life Science
    380.00K0.00
    Dr. Vecheslav A. Elagin Ph.D., 49
    Exec. VP of R&D
    361.00K0.00
    Mr. Marco G. Calzavara , 62
    Pres of Meridian Bioscience Europe and Managing Director of Meridian Bioscience Europe
    412.00K0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders